Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) CEO Kim Rivers sold 380,000 shares of Trulieve Cannabis stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $8.47, for a total value of $3,218,600.00. Following the transaction, the chief executive officer owned 2,313,724 shares in the company, valued at $19,597,242.28. This represents a 14.11% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trulieve Cannabis Price Performance
Trulieve Cannabis stock traded up $0.06 during mid-day trading on Thursday, hitting $8.56. The company’s stock had a trading volume of 2,007,316 shares, compared to its average volume of 576,130. Trulieve Cannabis Corp. has a 52-week low of $3.50 and a 52-week high of $13.28.
Wall Street Analysts Forecast Growth
TRLV has been the topic of several research reports. Weiss Ratings assumed coverage on shares of Trulieve Cannabis in a research note on Tuesday, June 16th. They issued a “sell (d-)” rating on the stock. Zacks Research upgraded shares of Trulieve Cannabis to a “hold” rating in a research note on Thursday, June 18th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Trulieve Cannabis has a consensus rating of “Reduce”.
About Trulieve Cannabis
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
See Also
- Five stocks we like better than Trulieve Cannabis
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
